NeuroBo Pharmaceuticals, based in Cambridge, Massachusetts, develops multi-modal therapies, including DA-1241 for MASH and Type 2 Diabetes, and DA-1726 for obesity. The company went public on August 5, 2016.
St Co Dong-A LTD bought 4,647,887 shares of MTVA on 8 May at $0.71 per share, worth a total of $3.3M. They now own 9,995,679 MTVA shares, or a 87% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.